The condensed criteria are below for the full methodology, jump to our complete ranking criteria
Medication alternatives to Januvia (Sitagliptin) If your healthcare provider prefers to put you on another treatment, they may suggest another DPP-4 inhibitor or an anti-diabetic medication in another drug class
doi: 10.1093/brain/awad010 Summary Keywords autism, pathophysiology, bioenergetics, subtypes, biomarker, metabolomic, stratification, mitochondria Citation Smith AM, Donley ELR, Ney DM, Amaral DG, Burrier RE and Natowicz MR (2023) Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergetics
Main Key Actives
Emerging markets in Asia-Pacific are rapidly gaining traction, driven by rising middle-class populations, increasing urbanization, and a cultural shift towards proactive health management
2.2 Risk factors for DPN On the other hand, the risk factors for DPN have been widely reported